Diseases Cached

Brucellosis: Symptoms, Treatments, Medications and Prevention

by · Published · Updated

Brucellosis is a zoonotic bacterial infection caused by the Brucella species. It primarily affects animals such as cattle, goats, sheep, pigs, and dogs, but it can be transmitted to humans through direct contact with infected animals or by consuming contaminated animal products. Brucellosis is a significant public health problem in many parts of the world and can cause a wide range of symptoms that may persist for long periods, leading to chronic health problems if not treated properly.

What is Brucellosis?

Brucellosis, also known as Malta fever, Mediterranean fever, or undulant fever, is a bacterial infection caused by several species of the genus Brucella. These bacteria primarily infect domestic and wild animals but can also infect humans through various modes of transmission.

Causative Agents

The main Brucella species responsible for human infection are:

  • Brucella melitensis: Commonly found in goats and sheep and is the most pathogenic species for humans.
  • Brucella abortus: Primarily infects cattle and is a common cause of human brucellosis.
  • Brucella suis: Found in pigs and can also infect humans.
  • Brucella canis: Associated with dogs and can cause human infection, though it is less common.

Transmission of Brucellosis

Humans can acquire brucellosis through several routes:

  • Direct contact with infected animals: Farmers, veterinarians, and slaughterhouse workers who come into direct contact with the tissues, blood, urine, or reproductive secretions of infected animals are at risk.
  • Consumption of contaminated animal products: Consuming unpasteurized dairy products (such as milk, cheese, or yogurt) from infected animals is a common way to contract the disease. Meat from infected animals can also transmit the infection if not properly cooked.
  • Inhalation of aerosolized bacteria: Laboratory workers or people who handle infected animals in abattoirs may inhale aerosolized Brucella bacteria.
  • Vertical transmission: Although rare, brucellosis can be transmitted from mother to fetus during pregnancy.

Brucellosis is rarely transmitted from person to person, making human-to-human transmission uncommon.

Stages of Brucellosis

Brucellosis can be classified into acute, subacute, and chronic stages:

  • Acute Brucellosis: Symptoms appear suddenly and last for less than 8 weeks.
  • Subacute Brucellosis: Symptoms are more gradual in onset and last for 8 weeks to a year.
  • Chronic Brucellosis: Symptoms persist for more than a year and may result in long-term complications.

Who is at Risk of Brucellosis?

Brucellosis is a zoonotic disease, meaning it primarily affects people who are exposed to infected animals or their products. Several groups are at higher risk of contracting the disease based on their occupation, location, and activities.

High-Risk Populations

1. People in Close Contact with Animals

Individuals who work with animals are at the highest risk of contracting brucellosis. This includes:

  • Farmers and Livestock Handlers: Those who raise and care for cattle, goats, sheep, pigs, and other livestock are at risk due to their frequent exposure to infected animals.
  • Veterinarians: Veterinarians may contract brucellosis while treating infected animals or during procedures such as assisting with animal births, handling reproductive tissues, or vaccinating livestock.
  • Slaughterhouse Workers: People who work in abattoirs are at risk of contracting brucellosis through direct contact with infected animal tissues and fluids, especially during the slaughtering process.

2. Consumers of Unpasteurized Dairy Products

Individuals who consume unpasteurized milk, cheese, or other dairy products made from the milk of infected animals are at risk of contracting brucellosis. This is a common route of transmission in regions where pasteurization practices are not widely implemented or where consumption of raw milk is culturally accepted.

3. Hunters and Wildlife Enthusiasts

Hunters who handle wild animals, particularly wild boars, can be exposed to brucellosis through contact with blood, tissues, or fluids of infected game animals. Wildlife workers or park rangers in regions where brucellosis is prevalent in wild animals may also be at risk.

4. Laboratory Workers

Laboratory personnel who handle Brucella cultures or work with clinical samples from infected animals or humans are at risk of brucellosis through accidental inhalation of aerosolized bacteria or accidental inoculation with contaminated needles.

5. People in Endemic Areas

Brucellosis is more common in certain parts of the world where livestock vaccination programs are not widespread and food safety practices are insufficient. People living in these regions are at higher risk, especially those who frequently consume unpasteurized dairy products or work with animals.

6. Travelers to Endemic Regions

Travelers to regions where brucellosis is endemic may be at risk if they consume unpasteurized dairy products or engage in activities that involve close contact with livestock or wildlife. The risk increases if travelers participate in agricultural activities or visit rural areas with limited veterinary services.

Symptoms of Brucellosis

The symptoms of brucellosis can vary widely depending on the stage of the disease, the species of Brucella involved, and the individual’s immune response. Brucellosis can be an acute, subacute, or chronic illness and may affect multiple organs and systems.

Early Symptoms

In the early stages of brucellosis, the symptoms may resemble those of other febrile illnesses such as influenza or malaria. These early symptoms often appear 2 to 4 weeks after exposure and may persist for several weeks or months.

1. Fever

  • Intermittent or undulating fever (hence the name “undulant fever”) is the most common symptom of brucellosis.
  • The fever may spike in the evening and subside by morning, with sweats during the fever episodes.

2. Fatigue and Weakness

  • People with brucellosis often experience extreme fatigue and weakness, which may persist even after the fever subsides.

3. Muscle and Joint Pain

  • Muscle aches (myalgia) and joint pain (arthralgia) are common symptoms, often affecting large joints such as the knees, hips, and spine.
  • In some cases, brucellosis can lead to more severe joint inflammation (arthritis) or back pain due to spinal involvement.

4. Headaches

  • Headaches are common in the early stages of brucellosis and may be persistent or severe.

5. Sweats

  • Profuse sweating, particularly at night, is a hallmark symptom of brucellosis. The sweating episodes may be drenching and are often associated with the fever spikes.

6. Loss of Appetite and Weight Loss

  • Loss of appetite (anorexia) and unintentional weight loss are common in brucellosis, particularly as the disease progresses.

Advanced Symptoms

As brucellosis progresses, it may affect multiple organs and systems, leading to more severe symptoms and complications.

1. Splenomegaly and Hepatomegaly

  • Enlargement of the spleen (splenomegaly) and liver (hepatomegaly) may occur in advanced cases of brucellosis. This can lead to abdominal discomfort and a feeling of fullness.

2. Arthritis

  • Brucellosis can cause arthritis in large joints, such as the knees, hips, and ankles. Chronic joint pain and inflammation may persist even after the infection has been treated.

3. Neurological Symptoms

  • In rare cases, brucellosis can affect the nervous system, leading to neurological symptoms such as meningitis, encephalitis, or peripheral neuropathy.

4. Endocarditis

  • Brucellosis can affect the heart, leading to endocarditis, an infection of the inner lining of the heart chambers and valves. Endocarditis is a serious complication that can be life-threatening without prompt treatment.

5. Recurrent Fevers

  • In chronic brucellosis, fever may recur intermittently over months or years, along with other systemic symptoms such as fatigue, joint pain, and muscle weakness.

Diagnosis of Brucellosis

Diagnosing brucellosis can be challenging due to the non-specific nature of its symptoms, which can mimic other febrile illnesses. A combination of clinical evaluation, laboratory tests, and imaging studies is used to confirm the diagnosis.

Clinical Evaluation

The first step in diagnosing brucellosis is a thorough clinical evaluation. Healthcare providers will inquire about the patient’s symptoms, history of contact with animals, consumption of unpasteurized dairy products, and recent travel to endemic areas. Key clinical signs such as fever, sweats, fatigue, and joint pain, along with a history of exposure to animals, should raise suspicion for brucellosis.

Laboratory Tests for Brucellosis

Several laboratory tests can confirm the diagnosis of brucellosis and distinguish it from other infections.

1. Blood Culture

Blood culture is the most definitive method for diagnosing brucellosis. The Brucella bacteria can be isolated from the blood, bone marrow, or other tissues.

  • Advantages: Blood culture can confirm the presence of the bacteria and provide information on the specific species of Brucella involved.
  • Disadvantages: Blood culture may take several days or weeks to yield results, and the sensitivity of the test decreases in chronic cases.

2. Serological Testing

Serological tests detect antibodies produced by the immune system in response to Brucella infection. These tests are commonly used to diagnose brucellosis, particularly in the later stages of the disease.

  • Standard Agglutination Test (SAT): The SAT is the most commonly used serological test for brucellosis. It measures the level of antibodies against Brucella antigens.
    • Advantages: Widely available and relatively simple to perform.
    • Disadvantages: False-negative results may occur in the early stages of infection or in immunocompromised individuals.
  • ELISA (Enzyme-Linked Immunosorbent Assay): ELISA tests can detect both IgM (early-stage) and IgG (late-stage) antibodies against Brucella. This test is more sensitive than the SAT and can be used to monitor the course of the disease.
    • Advantages: High sensitivity and specificity.
    • Disadvantages: May produce false positives due to cross-reactivity with other bacterial infections.

3. Polymerase Chain Reaction (PCR)

PCR is a molecular diagnostic technique used to detect the DNA of Brucella bacteria in blood or tissue samples. PCR is highly sensitive and specific and can provide rapid results.

  • Advantages: PCR can confirm the presence of Brucella bacteria in the early stages of infection, even when blood cultures are negative.
  • Disadvantages: PCR may not be widely available in all regions and requires specialized equipment and technical expertise.

4. Bone Marrow Culture

In cases where blood culture results are negative, bone marrow culture can be used to isolate the bacteria. Bone marrow culture is particularly useful in chronic cases of brucellosis, where the bacterial load in the blood may be low.

  • Advantages: High sensitivity, especially in chronic cases.
  • Disadvantages: Invasive procedure and may be uncomfortable for the patient.

Imaging Studies

In cases of suspected complications such as arthritis, spondylitis (inflammation of the spine), or endocarditis, imaging studies such as X-rays, ultrasound, CT scans, or MRI may be used to assess the extent of damage to bones, joints, or internal organs.

Treatments for Brucellosis

The treatment of brucellosis typically involves a combination of antibiotics to eradicate the infection and prevent relapse. Prompt and adequate treatment is essential to prevent the disease from becoming chronic or leading to serious complications.

Antibiotic Therapy

Antibiotic therapy is the cornerstone of treatment for brucellosis. The goal of treatment is to eliminate the bacteria from the body and reduce the risk of relapse. Due to the intracellular nature of Brucella bacteria, prolonged treatment with a combination of antibiotics is required to achieve a cure.

1. Doxycycline

Doxycycline is the most commonly used antibiotic for the treatment of brucellosis. It is typically combined with another antibiotic to improve treatment efficacy.

  • Dosage: Administered orally at a dose of 100 mg twice daily for 6 weeks.
  • Mechanism of Action: Doxycycline inhibits bacterial protein synthesis by binding to the bacterial ribosome, preventing the bacteria from growing and multiplying.
  • Side Effects: Common side effects include gastrointestinal upset, photosensitivity, and esophagitis. Doxycycline is contraindicated in pregnant women and children under 8 years old due to its effects on bone and tooth development.

2. Rifampin

Rifampin is often used in combination with doxycycline to treat brucellosis. This combination is recommended for its synergistic effect and its ability to prevent relapse.

  • Dosage: Administered orally at a dose of 600 to 900 mg once daily for 6 weeks.
  • Mechanism of Action: Rifampin inhibits bacterial RNA synthesis by binding to the bacterial RNA polymerase, preventing the bacteria from producing essential proteins.
  • Side Effects: Rifampin can cause liver toxicity, gastrointestinal symptoms, and orange discoloration of bodily fluids (e.g., urine, sweat, tears). It also interacts with many other medications, so careful monitoring is required.

3. Streptomycin or Gentamicin

In severe cases of brucellosis, particularly those with complications such as endocarditis or meningitis, an aminoglycoside antibiotic such as streptomycin or gentamicin may be added to the treatment regimen.

  • Streptomycin: Administered intramuscularly at a dose of 1 g daily for 2 to 3 weeks.
  • Gentamicin: Administered intravenously or intramuscularly at a dose of 5 mg/kg once daily for 7 to 10 days.
  • Mechanism of Action: Aminoglycosides bind to the bacterial ribosome and inhibit protein synthesis, leading to bacterial cell death.
  • Side Effects: Aminoglycosides can cause kidney toxicity and hearing loss, so renal function and hearing should be monitored during treatment.

4. Trimethoprim-Sulfamethoxazole (TMP-SMX)

TMP-SMX is another antibiotic that may be used in combination with doxycycline, particularly in children, pregnant women, or people who cannot tolerate rifampin.

  • Dosage: Administered orally at a dose of 160 mg/800 mg twice daily for 6 weeks.
  • Mechanism of Action: TMP-SMX inhibits bacterial folic acid synthesis, preventing the bacteria from growing and multiplying.
  • Side Effects: Common side effects include gastrointestinal upset, allergic reactions, and skin rashes.

Treatment Duration

The duration of antibiotic treatment for brucellosis is typically 6 weeks, but longer courses may be required in cases of chronic or complicated brucellosis. Treatment must be completed in full to prevent relapse, which is common if the infection is not fully eradicated.

Treatment of Complications

In cases where brucellosis leads to complications such as arthritis, spondylitis, or endocarditis, additional treatments may be required:

  • Joint Injections: In cases of arthritis, corticosteroid injections may be used to reduce joint inflammation and pain.
  • Surgery: Surgical intervention may be required in cases of severe bone or joint damage, abscess formation, or heart valve infection (endocarditis).
  • Supportive Care: In cases of meningitis or other neurological complications, hospitalization and supportive care may be necessary.

Common Medications for Brucellosis

Several antibiotics are commonly used to treat brucellosis, often in combination, to ensure effective eradication of the bacteria and prevent relapse. The most commonly used medications include:

1. Doxycycline

Doxycycline is the first-line treatment for brucellosis and is usually combined with rifampin or other antibiotics to improve treatment outcomes.

  • How It Works: Doxycycline inhibits bacterial protein synthesis by binding to the bacterial ribosome.
  • Side Effects: Common side effects include nausea, vomiting, photosensitivity, and esophagitis. Doxycycline is contraindicated in pregnant women and children under 8 years old.

2. Rifampin

Rifampin is often combined with doxycycline to treat brucellosis. This combination is particularly effective in preventing relapse and is commonly used in both acute and chronic cases.

  • How It Works: Rifampin inhibits bacterial RNA synthesis by binding to the bacterial RNA polymerase.
  • Side Effects: Liver toxicity, gastrointestinal symptoms, and interactions with other medications are the most common side effects.

3. Streptomycin or Gentamicin

In severe or complicated cases of brucellosis, streptomycin or gentamicin may be added to the treatment regimen.

  • How It Works: Aminoglycosides bind to the bacterial ribosome and inhibit protein synthesis, leading to bacterial cell death.
  • Side Effects: These medications can cause kidney toxicity and hearing loss, so careful monitoring is required.

4. Trimethoprim-Sulfamethoxazole (TMP-SMX)

TMP-SMX is often used as an alternative treatment for children, pregnant women, or people who cannot tolerate doxycycline or rifampin.

  • How It Works: TMP-SMX inhibits bacterial folic acid synthesis.
  • Side Effects: Common side effects include gastrointestinal upset, allergic reactions, and skin rashes.

Where is Brucellosis Most Prevalent?

Brucellosis is most prevalent in regions where animal husbandry is common, and livestock vaccination programs or food safety practices are insufficient. The disease is endemic in many parts of the world, particularly in areas where people have close contact with livestock or consume unpasteurized dairy products.

Geographic Distribution

1. Middle East and North Africa

Brucellosis is highly prevalent in the Middle East and North Africa, particularly in countries such as:

  • Turkey
  • Iran
  • Saudi Arabia
  • Egypt
  • Algeria

In these regions, the consumption of unpasteurized dairy products and close contact with livestock contribute to the high incidence of brucellosis.

2. Mediterranean Region

Countries in the Mediterranean Basin, including Italy, Spain, Portugal, Greece, and Malta, have historically reported high rates of brucellosis. However, control measures, such as livestock vaccination and improved food safety practices, have significantly reduced the incidence of the disease in recent years.

3. South and Central Asia

Brucellosis is common in South Asia, particularly in countries such as India, Pakistan, and Afghanistan, where close contact with livestock is common and food safety regulations may be less stringent. It is also reported in parts of Central Asia and China.

4. Sub-Saharan Africa

Brucellosis is a significant public health problem in many parts of Sub-Saharan Africa, particularly in pastoral communities that rely on livestock for their livelihood. Countries such as Kenya, Tanzania, Uganda, and Ethiopia have reported high rates of brucellosis.

5. Latin America

In Latin America, brucellosis is endemic in several countries, including Mexico, Brazil, Argentina, Peru, and Chile. Livestock farming and the consumption of unpasteurized dairy products contribute to the spread of the disease in these regions.

Prevention of Brucellosis

Preventing brucellosis involves a combination of strategies aimed at reducing human exposure to Brucella bacteria. This includes controlling the disease in animals, improving food safety practices, and raising awareness of the risks associated with brucellosis.

Animal Control Measures

Since brucellosis is primarily transmitted from animals to humans, controlling the disease in livestock is the most effective way to prevent human infection.

1. Vaccination of Livestock

Vaccinating livestock, particularly cattle, goats, and sheep, is a critical measure for preventing the spread of brucellosis. In many countries, vaccination programs have been implemented to reduce the incidence of brucellosis in domestic animals.

  • Brucella abortus and Brucella melitensis vaccines are commonly used to immunize cattle, goats, and sheep against the disease.
  • In countries with effective livestock vaccination programs, the incidence of human brucellosis has significantly decreased.

2. Animal Testing and Culling

Testing animals for brucellosis and culling infected animals can help control the spread of the disease. This is particularly important in livestock farms, where the disease can spread rapidly if not controlled.

  • Regular testing of livestock for brucellosis can help identify infected animals early, allowing for prompt isolation and culling to prevent further transmission.

3. Improving Veterinary Services

In many regions, improving veterinary services and providing access to brucellosis testing, vaccination, and treatment for animals can help reduce the burden of the disease in both animals and humans.

Food Safety Measures

Food safety practices play a critical role in preventing brucellosis, particularly in regions where unpasteurized dairy products are consumed.

1. Pasteurization of Dairy Products

Consuming pasteurized dairy products is one of the most effective ways to prevent brucellosis. Pasteurization kills Brucella bacteria and other pathogens that may be present in milk and dairy products.

  • Governments and public health organizations should promote the pasteurization of milk and educate the public about the risks of consuming raw milk or unpasteurized dairy products.

2. Safe Meat Handling and Cooking

Properly handling and cooking meat from livestock or wild game can prevent the transmission of brucellosis. The bacteria are killed by cooking meat to an internal temperature of at least 160°F (71°C).

  • People who handle raw meat, such as butchers or hunters, should wear protective gloves and wash their hands thoroughly after handling animal tissues.

3. Educating Consumers

Public health campaigns should educate consumers about the risks of brucellosis and encourage them to avoid consuming unpasteurized dairy products and improperly cooked meat.

Personal Protective Measures

Individuals who work with animals or handle animal products can reduce their risk of brucellosis by taking personal protective measures.

1. Wearing Protective Clothing

People who work with animals, particularly veterinarians, farmers, and slaughterhouse workers, should wear protective clothing, such as gloves, masks, and goggles, to reduce their exposure to animal fluids and tissues that may be contaminated with Brucella bacteria.

2. Practicing Good Hygiene

Good hygiene practices, such as washing hands thoroughly after handling animals or animal products, can help prevent the transmission of brucellosis. This is especially important for people who work in high-risk occupations, such as livestock farming or veterinary medicine.

3. Avoiding Contact with Infected Animals

People who work with livestock should avoid direct contact with animals that are known to be infected with brucellosis or are showing signs of illness. Infected animals should be isolated from healthy animals to prevent the spread of the disease.

Public Health Education

Public health education plays a key role in preventing brucellosis by raising awareness of the risks associated with the disease and promoting protective behaviors.

1. Community Education Campaigns

Community education campaigns can provide information on how brucellosis is transmitted, the importance of pasteurizing dairy products, and the need for proper livestock vaccination. These campaigns should target high-risk populations, such as farmers, livestock handlers, and rural communities.

2. Training Healthcare Workers

Healthcare workers in regions where brucellosis is prevalent should be trained to recognize the early signs and symptoms of the disease and provide appropriate treatment. Early diagnosis and treatment are crucial for preventing complications and reducing the burden of the disease.

You may also like...